These multiple, concurrent noncovalent interactions contribute to the biological activity of Nyctanthic acid by promoting strong and sustained inhibition of AKT1—a kinase heavily implicated in oral cancer pathogenesis via the PI3K‐Akt pathway. The gene discussed is AKT1; the disease is lip and oral cavity carcinoma.